Evidence map›Paper›PMID 21805091›Full record

ArticleMolecular and cellular biochemistry2012

OETMAP: a new feature encoding scheme for MHC class I binding prediction.

Murat Gök, Ahmet Turan Özcerit

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Murat GökSakarya University Science Institute, Sakarya, Turkey. muratgok@gmail.com
Ahmet Turan Özcerit

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deciphering the understanding of T cell epitopes is critical for vaccine development. As recognition of specific peptides bound to Major histocompatibility complex (MHC) class I molecules, cytotoxic T cells are activated. This is the major step to initiate of immune system response. Knowledge of the MHC specificity will enlighten the way of diagnosis, treatment of pathogens as well as peptide vaccine development. So far, a number of methods have been developed to predict MHC/peptide binding. In this article, a novel feature amino acid encoding scheme is proposed to predict MHC/peptide complexes. In the proposed method, we have combined orthonormal encoding (OE) and Taylor's Venn-diagram, and have used Linear support vector machines as the classifier in the tests. We also have compared our method to current feature encoding scheme techniques. The tests have been carried out on comparatively large Human leukocyte antigen (HLA)-A and HLA-B allele peptide three binding datasets extracted from the Immune epitope database and analysis resource. On three datasets experimented, the IC50 cutoff a criteria is used to select the binders and non-binders peptides. Experimental results show that our amino acid encoding scheme leads to better classification performance than other amino acid encoding schemes on a standalone classifier.

Indexed as

Binding SitesDatabases, ProteinEpitopes, T-LymphocyteHistocompatibility Antigens Class IHumansInhibitory Concentration 50MethodsPeptidesSupport Vector MachineEpitopes, T-LymphocyteHistocompatibility Antigens Class IPeptides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.